Navigation Links
Canadian Government Announces Funding for Leading Biotechnology Firm's Project
Date:3/6/2009

ificantly increasing feedstock yield per hectare of land.

These traits are just some of the technologies developed by the company, which include Yield Protection Technology(R) (YPT(R)) and other traits that stabilize seed yields in drought and heat conditions and improve seed size.

"Current assessments for the North American biofuels market indicate that over 1 billion tons of dry biomass per year will be required to switch current petroleum consumption to 30% renewable fuels," says Mr. Matthewman. "Non-food purpose grown energy crops can provide the yield per hectare necessary to sustainably and cost-efficiently support a new clean energy industrial sector."

PPI's next generation of non-food biofuel crops will also provide benefits to farmers by providing alternative crops such as switch grass, Miscanthus, sorghum and hemp that can be grown on marginal land with limited fertilizer and water requirements.

This next generation biofuel conversion technologies will be driven by PPI trait improvements have the potential to offer the necessary solutions for Canada to create a viable, profitable new clean energy industrial sector that use reliable, consistent, non-food feedstocks with superior processing characteristics, according to Mr. Matthewman. PPI is currently working with its partners to enable the value chain that will see these improvements brought to commercial reality.

    About Sustainable Development Technology Canada (SDTC)
    ------------------------------------------------------

Sustainable Development Technology Canada (SDTC) is an arm's-length foundation which has received $1.05 billion from the Government of Canada as part of its commitment to create a healthy environment and a high quality of life for all Canadians.

SDTC operates two funds aimed at the development and demonstration of innovative technological solutions. The $550 million SD Tech Fund(TM) supports project
'/>"/>

SOURCE Performance Plants Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
2. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
3. Kiwa Bio-Tech Products Group Discusses Cooperative Efforts With Canadian Agricultural Ministry and Canadian Company
4. BioElectronics Announces Canadian Retail Product Launch
5. CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies
6. Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing
7. Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
8. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
9. Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
10. New discoveries, new labs highlight international Canadian Light Source meeting
11. Aortic Stent Grafts Will Boost Canadian and Japanese Peripheral Vascular Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 30, 2015 Sanofi, ... for the second quarter of 2015. CEO ... and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in ... - Performance drivers - ...
(Date:7/29/2015)... 2015 US-Australian drug discovery company, Novogen Limited ... is committed to progressing its ground-breaking technology platforms to ... to ensure the Company delivers the best value for ... Ross , said the Company currently had an extensive ... discovery programs and academic partnerships and initiatives, and he ...
(Date:7/29/2015)...  HealthSouth Corporation (NYSE: HLS ), one ... services, offering both facility-based and home-based post-acute services, ... second quarter ended June 30, 2015. ... growth in both segments and an 11.0% increase ... and Chief Executive Officer of HealthSouth. "While reported ...
(Date:7/29/2015)... 29, 2015 Research ... addition of the "Global Biosimilars Market, 2015 ... The Global Biosimilars Market, 2015 - 2025, ... growing biosimilars market. With the blockbuster biologics losing ... costs, biosimilars are being viewed as viable substitutes ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27
... Nov. 20 MDV-Mohr Davidow Ventures, a,leading Silicon ... of,Phyllis Whiteley and Dan Riskin to the firm ... develop start-up,opportunities that provide healthcare providers and consumers ... from prevention to diagnosis to the,treatment of disease. ...
... China Medical Technologies, Inc.,(the "Company") (Nasdaq: ... develops, manufactures and markets advanced in-vitro diagnostic products,today ... of two,proprietary molecular diagnostic kits for the detection ... with non-small cell lung,cancer ("NSCLC"). The Company expects ...
... popular family Web sites, today announced a partnership ... for genealogic research. In addition to MyHeritage,s innovative ... also use information contained in their DNA to ... from many hundreds of years ago. FamilyTreeDNA users ...
Cached Biology Technology:MDV Expands Team Pursuing Advances in Personalized Medicine 2China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits 2MyHeritage And Family Tree DNA Partner To Help People Trace Family History Using DNA 2MyHeritage And Family Tree DNA Partner To Help People Trace Family History Using DNA 3MyHeritage And Family Tree DNA Partner To Help People Trace Family History Using DNA 4
(Date:7/31/2015)... , Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market and ... has filed provisional patent 62/198989 for ELECTRONIC ... highlights a method to advance crypto-currencies such as Bitcoin ... a common, uniform way to manage all payments.  ...
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading ... for its second quarter ended June 30, 2015.  ... million, a decrease of 33% compared to $6.8 million in ... quarter of 2015 was $0.3 million, or $0.01 per diluted ... share, in the same period a year ago.  ...
(Date:7/20/2015)... 20, 2015  Acuity Market Intelligence,s latest research ... of Commerce and Privacy" forecasts that between 2014 ... will be downloaded to smart mobile devices by ... market is projected to generate more than $67.9 ... seven-year forecast period.    "Biometrics is ...
Breaking Biology News(10 mins):NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... at the University of Chicago finds evidence for a ... of loneliness: They create people in their surroundings to ... very efficient way to alleviate ones loneliness, but you ... so, said Nicholas Epley, Assistant Professor of Behavioral Science ...
... French . Researchers at the ... neurological basis of depression in male athletes with persisting ... of Archives of General Psychiatry, has important clinical implications ... cerebral concussion. Depression is one of a ...
... German . Genetically engineered products have become ... future, gene therapy should make it possible to introduce genes ... can address deficiencies to compensate for malfunctions in the body. ... must be introduced into host cells, which is not exactly ...
Cached Biology News:People not always needed to alleviate loneliness 2People not always needed to alleviate loneliness 3MNI researchers locate neurological basis of depression following sports concussion 2Cells get sprayed 2